5uhi

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (14:27, 6 March 2024) (edit) (undo)
 
Line 3: Line 3:
<StructureSection load='5uhi' size='340' side='right'caption='[[5uhi]], [[Resolution|resolution]] 3.20&Aring;' scene=''>
<StructureSection load='5uhi' size='340' side='right'caption='[[5uhi]], [[Resolution|resolution]] 3.20&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
-
<table><tr><td colspan='2'>[[5uhi]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5UHI OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=5UHI FirstGlance]. <br>
+
<table><tr><td colspan='2'>[[5uhi]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5UHI OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5UHI FirstGlance]. <br>
-
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=8A4:(R)-(4-CHLORO-2-METHOXY-3-{[4-(1H-PYRAZOL-1-YL)PHENYL]METHYL}QUINOLIN-6-YL)(4-CHLOROPHENYL)(1-METHYL-1H-IMIDAZOL-5-YL)METHANOL'>8A4</scene></td></tr>
+
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3.198&#8491;</td></tr>
-
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=5uhi FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5uhi OCA], [http://pdbe.org/5uhi PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5uhi RCSB], [http://www.ebi.ac.uk/pdbsum/5uhi PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5uhi ProSAT]</span></td></tr>
+
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=8A4:(R)-(4-CHLORO-2-METHOXY-3-{[4-(1H-PYRAZOL-1-YL)PHENYL]METHYL}QUINOLIN-6-YL)(4-CHLOROPHENYL)(1-METHYL-1H-IMIDAZOL-5-YL)METHANOL'>8A4</scene></td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5uhi FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5uhi OCA], [https://pdbe.org/5uhi PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5uhi RCSB], [https://www.ebi.ac.uk/pdbsum/5uhi PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5uhi ProSAT]</span></td></tr>
</table>
</table>
== Function ==
== Function ==
-
[[http://www.uniprot.org/uniprot/RORG_HUMAN RORG_HUMAN]] Possible nuclear receptor for hydroxycholesterols, the binding of which strongly promotes coactivators recruitment. Essential for thymopoiesis and the development of several secondary lymphoid tissues, including lymph nodes. Involved in lineage specification of uncommitted CD4(+) T-helper cells into Th17 cells. Regulate the expression of several components of the circadian clock.
+
[https://www.uniprot.org/uniprot/RORG_HUMAN RORG_HUMAN] Possible nuclear receptor for hydroxycholesterols, the binding of which strongly promotes coactivators recruitment. Essential for thymopoiesis and the development of several secondary lymphoid tissues, including lymph nodes. Involved in lineage specification of uncommitted CD4(+) T-helper cells into Th17 cells. Regulate the expression of several components of the circadian clock.
-
<div style="background-color:#fffaf0;">
+
-
== Publication Abstract from PubMed ==
+
-
A high-throughput screen of the ligand binding domain of the nuclear receptor retinoic acid-related orphan receptor gamma t (RORgammat) employing a thermal shift assay yielded a quinoline tertiary alcohol hit. Optimization of the 2-, 3- and 4-positions of the quinoline core using structure-activity relationships and structure-based drug design methods led to the discovery of a series of modulators with improved RORgammat inhibitory potency and inverse agonism properties.
+
-
 
+
-
Identification and structure activity relationships of quinoline tertiary alcohol modulators of RORgammat.,Kummer DA, Cummings MD, Abad M, Barbay J, Castro G, Wolin R, Kreutter KD, Maharoof U, Milligan C, Nishimura R, Pierce J, Schalk-Hihi C, Spurlino J, Urbanski M, Venkatesan H, Wang A, Woods C, Xue X, Edwards JP, Fourie AM, Leonard K Bioorg Med Chem Lett. 2017 Feb 21. pii: S0960-894X(17)30163-4. doi:, 10.1016/j.bmcl.2017.02.044. PMID:28318945<ref>PMID:28318945</ref>
+
-
 
+
-
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
+
-
</div>
+
-
<div class="pdbe-citations 5uhi" style="background-color:#fffaf0;"></div>
+
-
== References ==
+
-
<references/>
+
__TOC__
__TOC__
</StructureSection>
</StructureSection>
 +
[[Category: Homo sapiens]]
[[Category: Large Structures]]
[[Category: Large Structures]]
-
[[Category: Abad, M]]
+
[[Category: Abad M]]
-
[[Category: Spurlino, J]]
+
[[Category: Spurlino J]]
-
[[Category: Nuclear hormone receptor]]
+
-
[[Category: Transcription]]
+

Current revision

Structure of RORgt bound to

PDB ID 5uhi

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/5uhi"
Personal tools